Rubicon Organics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rubicon Organics generated cash of $5,049,740, which is more than the previous year. Cash used in financing activities reached the amount of -$804,006 last year. Net change in cash is therefore $1,490,073.
Cash Flow
| 2017 | -4.19M | -9.02M | 12.77M |
|---|---|---|---|
| 2018 | -9.29M | -9.08M | 15.50M |
| 2019 | -10.68M | -5.33M | 17.75M |
| 2020 | -14.31M | 3.07M | 21.25M |
| 2021 | -10.44M | -5.49M | 15.30M |
| 2022 | 1.95M | -4.45M | -838.56K |
| 2023 | 5.04M | -2.73M | -804.00K |
ROMJ.V Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 8.29M | 11.58M | 12.13M | 2.08M | 232.42K | 2.92M | 3.63M |
Operating activities | |||||||
Net income | -1.82M | -3.85M | -14.52M | -14.98M | -14.27M | -29.87M | -5.85M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 3.12M | 3.05M | 2.39M | 1.71M | 1.62M | 258.36K | 175.58K |
Stock-based compensation expense | 1.38M | 3.04M | 2.14M | 2.55M | 3.16M | 0 | 932.00K |
| Deferred income tax benefit | 1.38M | 3.04M | 2.14M | 2.55M | 3.16M | 0 | 932.00K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 1.44M | -625.62K | -1.58M | -2.36M | 359.98K | -445.86K | 384 |
Inventories | 448.01K | -446.10K | -1.13M | -2.46M | -374.54K | -158.06K | 428.82K |
Accounts payable | 0 | 1.60M | 73.81K | 1.59M | -558.82K | 1.55M | 83.06K |
Cash generated by operating activities | 5.04M | 1.95M | -10.44M | -14.31M | -10.68M | -9.29M | -4.19M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -125.45K |
Investments In Property Plant And Equipment | -2.58M | -4.45M | -5.49M | -5.98M | -7.93M | -9.09M | -4.87M |
Acquisitions Net | 0 | 0 | 0 | 9.05M | 0 | 2.23K | -4.01M |
Cash generated by investing activities | -2.73M | -4.45M | -5.49M | 3.07M | -5.33M | -9.08M | -9.02M |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 21.22M | 13.31M | 7.57M | 15.37M | 8.36M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -107.00K | -171.11K | -14.02M | -1.23M | 10.16M | -68.46K | 2.89M |
Cash used in financing activities | -804.00K | -838.56K | 15.30M | 21.25M | 17.75M | 15.50M | 12.77M |
Net Change In Cash | 1.49M | -3.28M | -553.01K | 10.05M | 1.85M | -2.68M | -710.70K |
Cash at end of period | 9.78M | 8.29M | 11.58M | 12.13M | 2.08M | 232.42K | 2.92M |